Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Kendle | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: Kendle

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Kendle

4Q Revenues: $86.4 million (+64)

4Q Loss: $1.8 million (earnings were $5.2 million in 4Q2005)

FY Revenues: $283.5 million (+40%)

FY Earnings: $20.0 million (+16%)

Comments: New business awards were $164 million in the quarter. For the year, total business authorizations, which consist of signed backlog and verbally awarded business, totaled a record $659 million. Loss in the quarter includes an $8.2 million impairment charge related to the August acquisition of the Phase II-IV clinical services business of Charles River Laboratories International, Inc.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters